1.Relationship Between Emotional Intelligence and Coping Efficacy of College Students
Xiaoqiong HAN ; Xue ZHENG ; Biqun QIU ; Biaobin YAN
Chinese Journal of Clinical Psychology 1993;0(01):-
Objective:To study the relationship between emotional intelligence and coping efficacy of college students.Methods:220 college students in Guangdong province were selected as a sample to complete Emotional Intelligence Questionnaire and Coping Efficacy Scale.Results:①In the Emotional intelligence scores,the lower-grade students were higher than the higher-grade;cadre students were higher than the non-cadre students.②In the Coping efficacy scores,cadre students were higher than the non-cadre students'.③Emotional intelligence was positively correlated with coping efficacy,and competence perception;self-confidence degree and cognition level were mainly contributed to emotional intelligence.Conclusion:Emotional intelligence is positively correlated with coping efficacy.
2.Application of random forests regression in impact of family early disadvantaged risks on internalization problems in adolescents
Wenming XU ; Xiaoqiong HAN ; Haiyan YU ; Wenjie TANG
Chinese Journal of Behavioral Medicine and Brain Science 2021;30(7):627-633
Objective:To investigate the relationship between the type of exposure to early family disadvantaged risks and internalization problems in adolescents.Methods:Totally 746 adolescents were assessed with family disadvantaged risk items and Chinese version of Achenbach youth self-report (YSR-CV). The Welch's ANOVA test and post-hoc test were used to compare the scores of three different risk factors on internalization problems.The independent sample t-test was adopted to compare the scores of internalization problems between experienced 5 or more kinds of risk factors and less than 5.Pearson correlation analysis was used to test the correlation between the number of family risk factors experienced and the scores of internalization problems.Random forest regression analysis was used to test the variable importance(VI) of the internalization problem. Results:The differences in anxiety/depression and withdrawal scores between higher or lower-level risks group were significant ( P<0.05). The scores of adolescents with five or more adverse experiences on anxiety/depression(7.7±3.5), withdrawal (8.8±4.0) and physical problems(4.1±3.7) were higher than those with fewer than five risk factors(5.5±3.8), (6.7±3.4), (2.6±3.6). The cumulative family disadvantaged risk items was positively correlated with anxiety/depression( r=0.29, P<0.01), withdrawal( r=0.29, P<0.01), and physical symptoms ( r=0.26, P<0.01). The most important factor associated with anxiety/depression(VI=0.84, P=0.002; VI=0.56, P=0.022), withdrawal(VI=0.58, P=0.013; VI=0.89, P=0.001), and physical symptoms was marital relationship of parents and health status of family members. Conclusion:The parents’ marital relationship and health status of family members are the specific factors that influence the internalization problems, and the higher the level of risk adolescents experience, the more likely they are to develop internalization problems.
3.Research progress of biomarkers of hepatitis B virus and clinical significance.
Xin WANG ; Xiaoqiong TANG ; Ning HAN ; Hong TANG
Journal of Biomedical Engineering 2023;40(6):1242-1248
The infection of Hepatitis B virus (HBV) can result in severe consequences, including chronic hepatitis, liver fibrosis, cirrhosis, and even liver cancer. Effective antiviral treatment has the potential to slow down the progression of the disease. HBV serum biomarkers play a crucial role in the dynamic management of chronic hepatitis B (CHB) patients. However, the conventional hepatitis B virus markers, such as hepatitis B serologic testing and HBV DNA, are insufficient to meet the clinical requirements. This review provided a comprehensive overview of the current research on the quantification of HBsAg and anti-HBc, HBV RNA and HBV core-associated antigen, which summarized the crucial role these markers play in the administration of antiviral medications, predicting the efficacy of treatment and anticipating the likelihood of virologic rebound following drug cessation, as well as assessing disease progression in CHB patients.
Humans
;
Hepatitis B virus/genetics*
;
Clinical Relevance
;
Hepatitis B, Chronic/drug therapy*
;
Hepatitis B Core Antigens/therapeutic use*
;
Biomarkers
;
Liver Cirrhosis/drug therapy*
;
Antiviral Agents/therapeutic use*
;
Hepatitis B Surface Antigens/therapeutic use*
;
DNA, Viral/therapeutic use*
;
Hepatitis B e Antigens/therapeutic use*
;
Hepatitis B/drug therapy*